New Zealand Allows First Medical Use of Magic Mushroom Compound
Hi, it's Karoline in Singapore, where the use of hallucinogens is largely illegal and subject to severe penalties. But one nation just allowed medical use of 'magic mushrooms'. But before I tell you more...
Psilocybin, a hallucinogen found in more than 200 species of 'magic mushrooms' was defined by the UN's 1971 Convention on Psychotropic Substances as a drug with high potential for abuse and not recognized for medical use. But in recent years, studies have shown that it can relieve severe depression when taken in conjunction with psychotherapy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Just four doctors in clinic to see 300 patients a day? Health Ministry says aware of high load at Sg Buloh Hospital
SUNGAI BULOH, July 4 — The Health Ministry said it is aware of the high patient load at referral hospitals such as Sungai Buloh Hospital, following concerns that its doctors are overworked. After it was highlighted that the hospital's Orthopaedic Specialist Clinic had to see 300 patients on June 30, 2025, the ministry said the number had also included family members or caregivers. 'We understand the difficulties faced by patients and their families, especially concerning waiting times,' it posted on X yesterday. 'The Ministry of Health is aware of the high patient load at referral hospitals such as Sungai Buloh Hospital and continuous efforts are being made to improve patient flow.' The ministry said that its review showed that 158 patients attended the clinic that day. Dihantar olh seorang yang namanya tidak mahu dikenali. Dia membawa ahli keluarganya ke Hospital Sg Buloh semalam & terpaksa menunggu agak is extremely worrying & may be jeopardising both the workforce & the patients' wellbeing.@anwaribrahim@DrDzul @KKMPutrajaya — BarathiSelvam (@barathiSelvam10) July 1, 2025 'This is a common practice in public healthcare facilities, particularly for elderly patients and children,' it said, referring to the presence of family members and caregivers. It was responding to a social post with a photo of a notice for clinic staff, saying that merely three medical officers and one specialist were present to attend to 300 patients. 'The clinic was staffed by three specialists and three medical officers, in accordance with the existing schedule and capacity,' the ministry insisted, contradicting the clinic's notice.
Yahoo
7 hours ago
- Yahoo
Herbalife's Aloin Identification Method for Aloe Vera Officially Recognized by AOAC INTERNATIONAL
Certified Method Enhances Global Botanical Quality and Safety HONG KONG, July 4, 2025 /PRNewswire/ -- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the Association of Official Analytical Collaboration (AOAC INTERNATIONAL)—a global authority in analytical science—has formally certified its proprietary method for identifying and measuring anthraquinones, also known as aloins, in aloe vera. Aloe regulatory groups require producers of ingestible aloe vera products to monitor naturally occurring compounds such as aloin A, aloin B, and aloe-emodin to meet safety guidelines. This certification officially recognizes Herbalife's longstanding method as the world's first AOAC-approved approach for detecting aloins – reinforcing safety and quality benchmarks across botanical and dietary supplement industries. Developed by Herbalife scientists and validated by independent laboratories worldwide, this AOAC-certified method is used to test every batch of Herbalife's aloe-based products, ensuring safety, while preserving aloe vera's natural benefits. Aloe vera is a key ingredient in many of Herbalife's top products, which are sold in more than 90 markets. "This AOAC validation is an important milestone for Herbalife and the industry as a whole," said Gary Swanson, SVP of Global Quality at Herbalife and lead author of the study. "We are proud to lead scientific innovation that enhances botanical ingredient safety, benefitting not only Herbalife products and our customers, but also advancing standards across the industry." Herbalife's method was validated through a global multi-laboratory study involving eight independent laboratories. Each lab tested the same set of six aloe vera samples, including both raw materials and finished products, using HPLC (High-Performance Liquid Chromatography) to measure aloin A, aloin B, and aloe-emodin. The study ensured the method's accuracy and reliability across various labs and product types, with results confirming that it met all performance criteria, including precision and system suitability. "This multi-laboratory validation study supported approval of an analytical method developed by Herbalife scientists as the AOAC 2016.09 Official Final Action Method," said Dr. Katerina Mastovska, deputy executive director and chief science officer, AOAC INTERNATIONAL. "AOAC official methods undergo rigorous scientific evaluation and are highly credible and globally accepted. As such, this method will help strengthen botanical quality and safety standards worldwide." Herbalife has a long-standing commitment to aloe vera research and quality assurance. This dedication has resulted in five patents and three published studies focused on developing safe extraction methods that preserve the plant's natural benefits. While many companies rely solely on supplier certifications to confirm the authenticity of their aloe vera, Herbalife goes further. The company is one of the few in the world using advanced proton nuclear magnetic resonance (NMR) spectrometry—an analytical technique that uses magnetic fields and radio waves to identify the molecular structure of raw materials. This allows Herbalife to independently verify the identity and purity of its aloe vera at the molecular level, ensuring the highest standards of quality, consistency and traceability across its global supply chain. For 45 years, Herbalife has upheld a global commitment to quality through its rigorous Seed to Feed process. This comprehensive system ensures that every ingredient—from responsibly sourced crops cultivated by dedicated farmers to the finished product—meets stringent standards for identity, potency, safety, and purity. Herbalife performs internal testing in ISO 17025-accredited laboratories, verifying that ingredients comply with both company standards and government regulations. The company's science-backed approach, grounded in Good Manufacturing Practices (GMPs) and NSF International standards, delivers consistent, transparent products in more than 90 markets. Supported by a global team of scientists and quality experts, this process strengthens consumer trust and continues to advance industry standards worldwide. Herbalife's aloe vera testing method has been published in Journal of AOAC INTERNATIONAL (Volume 108, Issue 3, Pages 449-471). About Herbalife Ltd. Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit Media Contact: media@ View original content to download multimedia: SOURCE Herbalife Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
Alibaba seeking to raise $1.53 billion via exchangeable bonds
-- Chinese tech giant Alibaba (NYSE:BABA) Group announced Thursday it aims to raise approximately HK$12 billion ($1.53 billion) through exchangeable bonds to increase investments in cloud infrastructure and global commerce operations. The bonds will be linked to Alibaba Health Technology, in which Alibaba Group owns more than 44%. Investors who purchase these bonds will have the option to exchange them for shares in Alibaba Health at a later date. The bonds will not pay interest over time. This debt offering comes after Alibaba's $5 billion dual-currency bond issuance in November, which was the largest deal of its kind in the Asia-Pacific region during 2024. Related articles Alibaba seeking to raise $1.53 billion via exchangeable bonds takes neutral stance on Genmab ahead of portfolio, execution updates Meta Platforms upgraded but Needham warns of capital waste and rising risks Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
